Geistlich Biomaterials

Geistlich Biomaterials is a Swiss-based global leader in regenerative medicine, specializing in biomaterials for dental, orthopedic, and wound care applications. The company is renowned for its pioneering work in bone and tissue regeneration, particularly with its flagship products Geistlich Bio-Oss and Geistlich Bio-Gide, which are widely regarded as the clinical gold standards in oral surgery. As a division of the family-owned Geistlich Pharma AG, the firm emphasizes a science-led approach, with over 1,400 scientific publications supporting its product portfolio. Geistlich maintains a robust global presence with numerous subsidiaries and distribution partners, serving clinicians in over 90 countries. Their business model integrates intensive research and development with high-standard manufacturing processes located in Switzerland. Recently, the company has expanded its focus into sports medicine and advanced wound care, leveraging its expertise in collagen and bone substitute technologies.